J S Read

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 17:391-7. 1998
  2. ncbi request reprint Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 18:134-42. 1999
  3. ncbi request reprint Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 19:544-51. 2000
  4. ncbi request reprint Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    Ann N Y Acad Sci 918:115-21. 2000
  5. ncbi request reprint Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    J Acquir Immune Defic Syndr 26:236-45. 2001
  6. ncbi request reprint Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings
    L M Mofenson
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852, USA
    Lancet 362:1625-7. 2003
  7. pmc Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    HIV Med 9:875-82. 2008
  8. ncbi request reprint Acceptance of HIV-1 education & voluntary counselling/testing by & seroprevalence of HIV-1 among, pregnant women in rural south India
    N M Samuel
    The Tamil Nadu Dr M G R Medical University, Chennai, India
    Indian J Med Res 125:49-64. 2007
  9. pmc Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics
    E V Capparelli
    San Diego Schools of Medicine and Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA 92103, USA
    HIV Med 9:214-20. 2008

Collaborators

  • L M Mofenson
  • S Pahwa
  • M G Fowler
  • G A Fitzgerald
  • Stephen I Pelton
  • WILLIAM THOMAS SHEARER
  • Mark Mirochnick
  • Marshall E Smith
  • C Diaz
  • Bridie Thompson
  • Jane E Hitti
  • Sharon Nachman
  • P E Palumbo
  • Mary E Paul
  • Else Smith
  • E V Capparelli
  • N M Samuel
  • Barbara W Stechenberg
  • Maureen T Shannon
  • Jorge Gandia
  • Denise Ferraro
  • Pat Flynn
  • Gwendolyn B Scott
  • Spring Wettgen
  • Deb Goldman
  • Diane W Wara
  • S A Spector
  • F Aweeka
  • Lourdes Angel
  • Elvia Perez
  • Rodrigo Diaz
  • E M Thorpe
  • Chitra S Mani
  • M Foca
  • Arlene Buck
  • Hunter Hammill
  • Nina K Sublette
  • Edwin Thorpe
  • B Best
  • Ana M Melendrez
  • C Hu
  • Murli Purswani
  • A Stek
  • Michele Acker
  • Marya G Zlatnik
  • Ruth Tuomala
  • Mary Patricia Toye
  • LaShonda Spencer
  • Silvia Muniz
  • Marc Foca
  • Jennifer Griffin
  • Susan Marks
  • Margaret A Keller
  • Karen Hickman
  • Marie Beall
  • Amanda Cotter
  • S K Burchett
  • Nicole Falgout
  • Andrew D Hull
  • Alice Higgins
  • Linda Proctor
  • H Watts
  • Yvonne Rodriguez
  • Stefan Hagmann
  • Shantrice M Williams
  • Arlene Bardeguez
  • Shelly Buscher
  • E Jimenez
  • Anne Gershon
  • Debra J Ware
  • Mary Caffery
  • Audra Deveikis
  • Dorothy Pender
  • Francoise Kramer
  • H Van Hook
  • S Dharmarajan
  • V Junankar
  • J Chamberlin
  • D Collins
  • M Jacob
  • P Srijayanth
  • J Bethel

Detail Information

Publications9

  1. ncbi request reprint The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 17:391-7. 1998
    ..The objectives of the study were to evaluate the immunogenicity of Hib conjugate vaccines among HIV-infected children according to clinical and immunologic disease progression as well as viral load...
  2. ncbi request reprint Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 18:134-42. 1999
    ....
  3. ncbi request reprint Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 19:544-51. 2000
    ....
  4. ncbi request reprint Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    Ann N Y Acad Sci 918:115-21. 2000
    ..In summary, the benefit of ECS must be weighed against potential risks, and issues such as cost-effectiveness also should be taken into consideration...
  5. ncbi request reprint Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    J Acquir Immune Defic Syndr 26:236-45. 2001
    ....
  6. ncbi request reprint Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings
    L M Mofenson
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852, USA
    Lancet 362:1625-7. 2003
    ..0001) and serum albumin (p=0.0107) independently predicted mortality. Further assessment of these markers is warranted in resource-poor settings...
  7. pmc Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    HIV Med 9:875-82. 2008
    ..Our objective was to evaluate the pharmacokinetics of nelfinavir (NFV) (625 mg tablets) 1250 mg twice daily during pregnancy and postpartum...
  8. ncbi request reprint Acceptance of HIV-1 education & voluntary counselling/testing by & seroprevalence of HIV-1 among, pregnant women in rural south India
    N M Samuel
    The Tamil Nadu Dr M G R Medical University, Chennai, India
    Indian J Med Res 125:49-64. 2007
    ....
  9. pmc Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics
    E V Capparelli
    San Diego Schools of Medicine and Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA 92103, USA
    HIV Med 9:214-20. 2008
    ..To determine the impact of pregnancy on the pharmacokinetics (PK) of nevirapine (NVP) during chronic dosing in HIV-infected women and appropriate NVP dosing in this population...